NO20053304D0 - NOGO A bindingsmolekyler og farmasoytisk anvendelse av disse. - Google Patents

NOGO A bindingsmolekyler og farmasoytisk anvendelse av disse.

Info

Publication number: NO20053304D0
Authority: NO; Norway
Prior art keywords: human; nogo; binding molecule; binding molecules; pharmaceutical use
Prior art date: 2002-12-10

Application number

NO20053304A

Other languages

English (en)

Other versions

NO20053304L (no

Inventor

Martin E Schwab

Carmen Barske

Anis Khusro Mir

Thomas Oertle

Lisa Schnell

Alessandra Vitaliti

Mauro Zurini

Original Assignee

Univ Zuerich Prorektorat Forsc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-10

Filing date

2005-07-06

Publication date

2005-07-06

2005-07-06 Application filed by Univ Zuerich Prorektorat Forsc filed Critical Univ Zuerich Prorektorat Forsc

2005-07-06 Publication of NO20053304D0 publication Critical patent/NO20053304D0/no

2005-09-07 Publication of NO20053304L publication Critical patent/NO20053304L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Psychiatry (AREA)
Zoology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Microbiology (AREA)
Mycology (AREA)
Ophthalmology & Optometry (AREA)
Psychology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO20053304A 2002-12-10 2005-07-06 NOGO A bindingsmolekyler og farmasoytisk anvendelse av disse NO20053304L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0228832.2A GB0228832D0 (en)	2002-12-10	2002-12-10	Organic compound
PCT/EP2003/013960 WO2004052932A2 (en)	2002-12-10	2003-12-09	Antibody (“11c7”) anti nogo a and its pharmaceutical use

Publications (2)

Publication Number	Publication Date
NO20053304D0 true NO20053304D0 (no)	2005-07-06
NO20053304L NO20053304L (no)	2005-09-07

Family

ID=9949456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053304A NO20053304L (no)	2002-12-10	2005-07-06	NOGO A bindingsmolekyler og farmasoytisk anvendelse av disse

Country Status (25)

Country	Link
US (2)	US7785593B2 (no)
EP (1)	EP1572745B1 (no)
JP (1)	JP4504200B2 (no)
KR (1)	KR101215801B1 (no)
CN (1)	CN100384877C (no)
AT (1)	ATE475671T1 (no)
AU (1)	AU2003289998B2 (no)
BR (1)	BR0317161A (no)
CA (1)	CA2509068C (no)
CY (1)	CY1110848T1 (no)
DE (1)	DE60333585D1 (no)
DK (1)	DK1572745T3 (no)
EC (1)	ECSP055849A (no)
ES (1)	ES2349293T3 (no)
GB (1)	GB0228832D0 (no)
HK (1)	HK1084676A1 (no)
IL (1)	IL169018A (no)
MX (1)	MXPA05006265A (no)
NO (1)	NO20053304L (no)
PL (1)	PL210720B1 (no)
PT (1)	PT1572745E (no)
RU (1)	RU2350623C2 (no)
SI (1)	SI1572745T1 (no)
WO (1)	WO2004052932A2 (no)
ZA (1)	ZA200504522B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0228832D0 (en)	2002-12-10	2003-01-15	Novartis Ag	Organic compound
GB0321997D0 (en) *	2003-09-19	2003-10-22	Novartis Ag	Organic compound
EP1711530B1 (en) *	2003-12-22	2009-08-26	Glaxo Group Limited	Nogo-a neutralising immunoglobulins for treatment of neurological diseases
CA2614076A1 (en) *	2005-07-05	2007-01-11	Glaxo Group Limited	Humanised antibodies specific for nogo-a and pharmaceutical uses thereof
GB0525662D0 (en)	2005-12-16	2006-01-25	Glaxo Group Ltd	Immunoglobulins
BRPI0818928B1 (pt) *	2007-11-02	2021-12-07	Novartis Ag	Moléculas de ligação a nogo-a isoladas, seu método de produção e seu uso, polinucleotídeo isolado, vetor e sistema de expressão, célula hospedeira isolada, e composição farmacêutica
US20110268729A1 (en) *	2008-07-11	2011-11-03	Bams Abila	Treatment of amyotrophic lateral sclerosis by nogo-a-antagonist
WO2012004773A1 (en)	2010-07-09	2012-01-12	Universite De Geneve	New uses of nogo-a inhibitors and related methods
EP2870177A1 (en)	2012-07-05	2015-05-13	Glaxo Group Limited	Optimum dose regime of an anti-nogo-a antibody in the treatment of amyotrophic lateral sclerosis
US9534044B2 (en) *	2013-02-28	2017-01-03	United Arab Emirates University	Alpha-synuclein antibodies and uses thereof
JP6604942B2 (ja) *	2013-06-13	2019-11-13	バイオマトリカ，インク．	細胞安定化
BR112018067522A2 (pt)	2016-03-01	2019-02-05	Univ Of Rijeka Faculty Of Medicine	anticorpos específicos para receptor de poliovírus humano (pvr)
CA3158491A1 (en)	2019-10-24	2021-04-29	Novago Therapeutics Ag	Novel anti-nogo-a antibodies

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8308573D0 (en)	1983-03-29	1983-05-05	British Nuclear Fuels Ltd	Filament impregnating/coating
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
ATE87659T1 (de)	1986-09-02	1993-04-15	Enzon Lab Inc	Bindungsmolekuele mit einzelpolypeptidkette.
IL162181A (en)	1988-12-28	2006-04-10	Pdl Biopharma Inc	A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5180820A (en)	1989-08-30	1993-01-19	Barde Yves Alain	Brain-derived neurotrophic factor
SK281143B6 (sk) *	1991-03-06	2000-12-11	Merck Patent Gesellschaft Mit Beschr�Nkter Haftung	Chimérická monoklonálna protilátka, expresné vektory a farmaceutický prostriedok
EP1098972B1 (en)	1998-07-22	2010-09-29	SmithKline Beecham Limited	Protein similar to neuroendocrine-specific protein, and encoding cdna
US7781188B1 (en)	1998-11-06	2010-08-24	University Of Zurich	Nucleotide and protein sequences of Nogo genes and methods based thereon
CU22921A1 (es)	1999-11-16	2004-02-20	Centro Inmunologia Molecular	Anticuerpos quimérico, humanizado y el fragmento de tipo fv de cadena sencilla que reconoce el antígeno c2. su uso en el diagnóstico y tratamiento de tumores colorrectales
EE200200386A (et)	2000-01-12	2003-12-15	Yale University	Nogo-retseptoriga vahendatud aksonikasvu blokaad
WO2002088306A2 (en) *	2001-04-30	2002-11-07	Eli Lilly And Company	Humanized antibodies
DE20110806U1 (de)	2001-06-29	2001-12-20	Jack Wolfskin Ausrüstung für Draussen GmbH, 65510 Idstein	Zelt
WO2003048083A2 (en) *	2001-11-30	2003-06-12	Biogen Idec Ma Inc.	Antibodies against monocyte chemotactic proteins
GB0228832D0 (en)	2002-12-10	2003-01-15	Novartis Ag	Organic compound
EP1711530B1 (en) *	2003-12-22	2009-08-26	Glaxo Group Limited	Nogo-a neutralising immunoglobulins for treatment of neurological diseases
US7596225B2 (en) *	2005-06-30	2009-09-29	Alcatl-Lucent Usa Inc.	Method for refreshing a pairwise master key

2002
- 2002-12-10 GB GBGB0228832.2A patent/GB0228832D0/en not_active Ceased
2003
- 2003-12-09 PT PT03782350T patent/PT1572745E/pt unknown
- 2003-12-09 US US10/538,201 patent/US7785593B2/en not_active Expired - Fee Related
- 2003-12-09 AT AT03782350T patent/ATE475671T1/de active
- 2003-12-09 MX MXPA05006265A patent/MXPA05006265A/es active IP Right Grant
- 2003-12-09 SI SI200331887T patent/SI1572745T1/sl unknown
- 2003-12-09 RU RU2005121669/13A patent/RU2350623C2/ru not_active IP Right Cessation
- 2003-12-09 WO PCT/EP2003/013960 patent/WO2004052932A2/en active Application Filing
- 2003-12-09 DE DE60333585T patent/DE60333585D1/de not_active Expired - Lifetime
- 2003-12-09 CA CA2509068A patent/CA2509068C/en not_active Expired - Fee Related
- 2003-12-09 JP JP2004558049A patent/JP4504200B2/ja not_active Expired - Fee Related
- 2003-12-09 ES ES03782350T patent/ES2349293T3/es not_active Expired - Lifetime
- 2003-12-09 EP EP03782350A patent/EP1572745B1/en not_active Expired - Lifetime
- 2003-12-09 KR KR1020057010410A patent/KR101215801B1/ko not_active Expired - Fee Related
- 2003-12-09 BR BR0317161-2A patent/BR0317161A/pt active Search and Examination
- 2003-12-09 CN CNB2003801096228A patent/CN100384877C/zh not_active Expired - Fee Related
- 2003-12-09 DK DK03782350.7T patent/DK1572745T3/da active
- 2003-12-09 AU AU2003289998A patent/AU2003289998B2/en not_active Ceased
- 2003-12-09 PL PL377506A patent/PL210720B1/pl unknown
2005
- 2005-06-06 IL IL169018A patent/IL169018A/en not_active IP Right Cessation
- 2005-06-10 EC EC2005005849A patent/ECSP055849A/es unknown
- 2005-07-06 NO NO20053304A patent/NO20053304L/no not_active Application Discontinuation
2006
- 2006-02-08 ZA ZA200504522A patent/ZA200504522B/en unknown
- 2006-02-24 HK HK06102543.2A patent/HK1084676A1/xx not_active IP Right Cessation
2010
- 2010-06-18 US US12/819,060 patent/US8535666B2/en not_active Expired - Fee Related
- 2010-10-19 CY CY20101100934T patent/CY1110848T1/el unknown

Also Published As

Publication number	Publication date
KR20050095768A (ko)	2005-09-30
EP1572745B1 (en)	2010-07-28
US20060183678A1 (en)	2006-08-17
IL169018A (en)	2012-07-31
WO2004052932A2 (en)	2004-06-24
DK1572745T3 (da)	2010-10-25
NO20053304L (no)	2005-09-07
PL210720B1 (pl)	2012-02-29
CN1747971A (zh)	2006-03-15
GB0228832D0 (en)	2003-01-15
WO2004052932A3 (en)	2004-10-21
CN100384877C (zh)	2008-04-30
CY1110848T1 (el)	2015-06-10
AU2003289998A1 (en)	2004-06-30
DE60333585D1 (de)	2010-09-09
US20110059110A1 (en)	2011-03-10
MXPA05006265A (es)	2005-12-05
RU2005121669A (ru)	2007-01-20
ECSP055849A (es)	2005-09-20
JP4504200B2 (ja)	2010-07-14
ZA200504522B (en)	2006-03-29
AU2003289998B2 (en)	2008-02-14
US8535666B2 (en)	2013-09-17
US7785593B2 (en)	2010-08-31
PT1572745E (pt)	2010-10-21
HK1084676A1 (en)	2006-08-04
JP2006523087A (ja)	2006-10-12
ATE475671T1 (de)	2010-08-15
KR101215801B1 (ko)	2012-12-26
EP1572745A2 (en)	2005-09-14
ES2349293T3 (es)	2010-12-29
CA2509068C (en)	2012-02-07
SI1572745T1 (sl)	2010-12-31
BR0317161A (pt)	2005-11-01
RU2350623C2 (ru)	2009-03-27
CA2509068A1 (en)	2004-06-24
PL377506A1 (pl)	2006-02-06

Publication	Publication Date	Title
CY1110848T1 (el)	2015-06-10	Αντισωμα αντι ανθρωπου νοgo α kai h φαρμακευτικη του χρηση
ECSP056263A (es)	2006-04-19	Anticuerpos humanizados que reconocen el péptido beta amiloideo
CY1117387T1 (el)	2017-04-26	ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
ATE416190T1 (de)	2008-12-15	Polypeptide mit bindungsaffinität für her2
EA200901436A1 (ru)	2010-10-29	Антигенсвязывающие белки, связывающие par-2
EA200801509A1 (ru)	2008-12-30	Человеческие моноклональные антитела к протеинтирозинкиназе 7 ( ptk7) и способы применения антител против ptk7
ATE492563T1 (de)	2011-01-15	Vollständige humane monoklonale antikörper gegen il-13
EA200700136A1 (ru)	2007-08-31	Анти-cd154-антитела
BRPI0715660B8 (pt)	2021-05-25	anticorpo isolado que se liga a il-31 humana, e, uso de um anticorpo monoclonal
WO2006083964A3 (en)	2009-04-30	Modified fusion molecules for treatment of allergic disease
DE602004016499D1 (de)	2008-10-23	Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
WO2007039256A3 (de)	2007-07-05	Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
TNSN06085A1 (en)	2007-10-03	Nogo-a binding with enhanced affinity and pharmaceutical use thereof
DE602006020333D1 (de)	2011-04-07	Multimere fc-rezeptor-polypeptide
TW200635946A (en)	2006-10-16	Binding proteins specific for human matriptase
DE69931482D1 (de)	2006-06-29	Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
DE60228504D1 (de)	2008-10-02	P53 bindende t-zellrezeptormoleküle und deren verwendungen
MXPA05007940A (es)	2007-06-14	Composiciones y metodos para el tratamiento del cancer usando igsf9 y liv-1.
PE20090981A1 (es)	2009-08-13	Moleculas aglutinantes de nogo-a mejoradas y uso farmaceutico de las mismas
WO2004032832A3 (en)	2004-10-21	Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment
Cozma	2014	Determination of Primary Structure and Affinity Characterization of Naturally Occurring β-Amyloid Autoantibodies
Cai et al.	2007	Identification of a cysteine-histidine thioether bridge bond in functional units d, e and f of β</inf> c<//inf>-haemocyanin of the gastropod Helix pomatia
CY1115920T1 (el)	2017-01-25	Αντι-gm-csf αντισωματα και χρησεις αυτων

Legal Events

Date	Code	Title	Description
2016-08-15	FC2A	Withdrawal, rejection or dismissal of laid open patent application